Pancreatic Cancer Research

ResearcherAcademy of Military Medical SciencesNo recent work listed

Jianming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4467-6021; OpenAlex author ID A5100726667. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Co-author DOI 10.1200/jco.22.02630↗
  2. S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancreatic cancer: a randomized, open-label, m… Last author DOI 10.1634/theoncologist.2014-0223↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunyi Hao · 1 shared paper, 2023 · strength 0.13
  2. Tianshu Liu · 1 shared paper, 2023 · strength 0.13
  3. Ying Yuan · 1 shared paper, 2023 · strength 0.13
  4. Hongmei Zhang · 1 shared paper, 2023 · strength 0.13
  5. Lin Yang · 1 shared paper, 2023 · strength 0.13
  6. Lin Shen · 1 shared paper, 2023 · strength 0.13
  7. Rui‐Hua Xu · 1 shared paper, 2023 · strength 0.13
  8. Qingshan Zheng · 1 shared paper, 2023 · strength 0.13
  9. Jin Li · 1 shared paper, 2023 · strength 0.13
  10. Jun Zhang Zhang · 1 shared paper, 2023 · strength 0.13
  11. Shukui Qin · 1 shared paper, 2023 · strength 0.13
  12. Deliang Fu · 1 shared paper, 2023 · strength 0.13
  13. Fei-Jiao Ge · 1 shared paper, 2014 · strength 0.04
  14. Fei Li · 1 shared paper, 2014 · strength 0.04
  15. Yanqiao Zhang · 1 shared paper, 2014 · strength 0.04
  16. Yi Ba · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.